Bringing Private Payers To The Regulatory Table: FDA Reaches Out To Insurers
This article was originally published in The Gray Sheet
Executive Summary
The agency's device center put out a request to health insurers to make themselves available to participate in FDA pre-submission meetings so that device firms, particularly start-ups, can better understand data expectations for coverage while companies are still designing studies to support FDA approval.